ArticleCancers2018

Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines.

Ryohei Kozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.